Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
AGTC, appeal, billion, cap, Code, comprised, decision, downturn, earned, economy, eye, gene, Genetic, hearing, individual, linked, panel, payroll, pertinent, project, recovery, taxpayer, withheld
Removed:
disruption, DMC, ending, experiencing, January, pharmacokinetic, rating, security, shareholder, turmoil, world
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Agreement for Purchase and Sale of Patent Rights and License Back Agreement
- 31.1 Certification of CEO Pursuant to Exchange Act Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Exchange Act Rule 13A-14(A)
- 32.1 Certification of CEO Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of CFO Pursuant to 18 U.s.c. Section 1350
Related press release
Icagen similar filings
Filing view
External links